• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用实时 PCR 和遗传多样性高分辨率熔解分析鉴定治疗后疟疾患者中的复发疟原虫。

Identifying Recrudescent Plasmodium falciparum in Treated Malaria Patients by Real-time PCR and High Resolution Melt Analysis of Genetic Diversity.

机构信息

Department of Immunology & Infection, Faculty of Infectious & Tropical Disease, London School of Hygiene & Tropical Medicine, London, United Kingdom.

Malaria Research and Training Centre (MRTC), Department of Epidemiology of Parasitic Diseases, Faculty of Pharmacy, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.

出版信息

Sci Rep. 2018 Jul 4;8(1):10097. doi: 10.1038/s41598-018-28179-2.

DOI:10.1038/s41598-018-28179-2
PMID:29973679
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6031682/
Abstract

Recurrent parasitaemia during follow up of clinical trials of antimalarial drug efficacy results from either recrudescence of parasites surviving treatment or from parasites newly emerging from the hepatic stage of infection. Nested PCR is used to distinguish these two possibilities and the technique is difficult to standardise. There is risk of both false positive and false negative results, leading to misclassification errors. The high-resolution melt (HRM) assay was developed with pairs of conserved primers targeting blocks of merozoite surface protein 1 and 2 (msp1 and msp2) genes, and polymorphisms were compared using sequence-confirmed Plasmodium falciparum DNA samples from laboratory isolates. In this study, the HRM dissociation profiles of msp1 and msp2 amplicons were determined and validated against parasite isolates from malaria patients. The msp1 and msp2 profiles of both laboratory and clinical isolates were reproducibly differentiated by HRM. These rapid assays are performed in a closed-tube system, and so avoid cross-contamination while increasing throughput, which are two major advantages. The HRM assays offer significant gains in simplicity, speed and interpretation of results, and reduced analysis cost, for studies that require discrimination of parasite clones. Assay performance in large-scale studies utilizing DNA samples derived from filter-paper bloodspots should now be evaluated.

摘要

在抗疟药物疗效临床试验的随访中,反复出现寄生虫血症是由于治疗后存活的寄生虫复发或新出现的来自感染肝期的寄生虫所致。巢式 PCR 用于区分这两种可能性,该技术难以标准化。存在假阳性和假阴性结果的风险,导致分类错误。高分辨率熔解(HRM)分析是使用针对裂殖子表面蛋白 1 和 2(msp1 和 msp2)基因的保守引物对开发的,并用经过序列确认的来自实验室分离株的恶性疟原虫 DNA 样本比较多态性。在这项研究中,确定了 msp1 和 msp2 扩增子的 HRM 解离曲线,并针对来自疟疾患者的寄生虫分离株进行了验证。HRM 可重复性地区分实验室和临床分离株的 msp1 和 msp2 图谱。这些快速检测在封闭管系统中进行,因此在增加通量的同时避免了交叉污染,这是两个主要优势。对于需要区分寄生虫克隆的研究,HRM 检测在结果的简单性、速度和解释方面具有显著优势,并降低了分析成本。现在应该评估利用滤纸片血斑衍生的 DNA 样本进行大规模研究的检测性能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73b5/6031682/4117cf792352/41598_2018_28179_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73b5/6031682/ce17bfd3034c/41598_2018_28179_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73b5/6031682/08f0c7371760/41598_2018_28179_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73b5/6031682/91e2101346f9/41598_2018_28179_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73b5/6031682/8a50f4da0acc/41598_2018_28179_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73b5/6031682/96efd83a4f2e/41598_2018_28179_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73b5/6031682/4117cf792352/41598_2018_28179_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73b5/6031682/ce17bfd3034c/41598_2018_28179_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73b5/6031682/08f0c7371760/41598_2018_28179_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73b5/6031682/91e2101346f9/41598_2018_28179_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73b5/6031682/8a50f4da0acc/41598_2018_28179_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73b5/6031682/96efd83a4f2e/41598_2018_28179_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73b5/6031682/4117cf792352/41598_2018_28179_Fig6_HTML.jpg

相似文献

1
Identifying Recrudescent Plasmodium falciparum in Treated Malaria Patients by Real-time PCR and High Resolution Melt Analysis of Genetic Diversity.利用实时 PCR 和遗传多样性高分辨率熔解分析鉴定治疗后疟疾患者中的复发疟原虫。
Sci Rep. 2018 Jul 4;8(1):10097. doi: 10.1038/s41598-018-28179-2.
2
Plasmodium falciparum msp1 and msp2 genetic diversity and allele frequencies in parasites isolated from symptomatic malaria patients in Bobo-Dioulasso, Burkina Faso.布基纳法索博博迪乌拉索症状性疟疾病例中分离的恶性疟原虫 msp1 和 msp2 基因多样性和等位基因频率。
Parasit Vectors. 2018 May 30;11(1):323. doi: 10.1186/s13071-018-2895-4.
3
Plasmodium falciparum msp1, msp2 and glurp allele frequency and diversity in sub-Saharan Africa.恶性疟原虫 msp1、msp2 和 glurp 等位基因在撒哈拉以南非洲的频率和多样性。
Malar J. 2011 Apr 6;10:79. doi: 10.1186/1475-2875-10-79.
4
Optimization and validation of multi-coloured capillary electrophoresis for genotyping of Plasmodium falciparum merozoite surface proteins (msp1 and 2).用于恶性疟原虫裂殖子表面蛋白(msp1和msp2)基因分型的多色毛细管电泳的优化与验证
Malar J. 2009 Apr 23;8:78. doi: 10.1186/1475-2875-8-78.
5
Evaluation of parasite subpopulations and genetic diversity of the msp1, msp2 and glurp genes during and following artesunate monotherapy treatment of Plasmodium falciparum malaria in Western Cambodia.评价柬埔寨西部恶性疟原虫青蒿琥酯单药治疗期间和之后虫株亚群及 msp1、msp2 和 glurp 基因遗传多样性。
Malar J. 2013 Nov 9;12:403. doi: 10.1186/1475-2875-12-403.
6
Genotyping methods to distinguish Plasmodium falciparum recrudescence from new infection for the assessment of antimalarial drug efficacy: an observational, single-centre, comparison study.基因分型方法区分疟原虫复发和新感染以评估抗疟药物疗效:一项观察性、单中心、比较研究。
Lancet Microbe. 2024 Nov;5(11):100914. doi: 10.1016/S2666-5247(24)00153-8. Epub 2024 Oct 17.
7
Genetic diversity and allele frequencies of Plasmodium falciparum msp1 and msp2 in parasite isolates from Bioko Island, Equatorial Guinea.来自赤道几内亚比奥科岛疟原虫分离株的 msp1 和 msp2 的遗传多样性和等位基因频率。
Malar J. 2018 Dec 7;17(1):458. doi: 10.1186/s12936-018-2611-z.
8
Molecular surveillance and temporal monitoring of malaria parasites in focal Vietnamese provinces.越南重点省份疟原虫的分子监测和时间监测。
Malar J. 2020 Dec 31;19(1):458. doi: 10.1186/s12936-020-03561-6.
9
Low genetic diversity of Plasmodium falciparum merozoite surface protein 1 and 2 and multiplicity of infections in western Ethiopia following effective malaria interventions.在有效疟疾干预措施实施后,埃塞俄比亚西部恶性疟原虫裂殖子表面蛋白 1 和 2 的遗传多样性低,感染程度多样。
Malar J. 2022 Dec 15;21(1):383. doi: 10.1186/s12936-022-04394-1.
10
Allelic diversity of merozoite surface protein genes (msp1 and msp2) and clinical manifestations of Plasmodium falciparum malaria cases in Aceh, Indonesia.印度尼西亚亚齐省间日疟原虫裂殖子表面蛋白基因(msp1 和 msp2)的等位基因多样性与临床表现。
Malar J. 2021 Apr 13;20(1):182. doi: 10.1186/s12936-021-03719-w.

引用本文的文献

1
Application of a high-resolution melt assay for monitoring SARS-CoV-2 variants in Burkina Faso and Kenya.高分辨率熔解分析在布基纳法索和肯尼亚监测严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体中的应用。
mSphere. 2025 Jun 25;10(6):e0002725. doi: 10.1128/msphere.00027-25. Epub 2025 May 29.
2
WHO malaria nucleic acid amplification test external quality assessment scheme: results of eleven distributions over 6 years.世界卫生组织疟疾核酸扩增检测外部质量评估方案:6年期间11次分发的结果
Malar J. 2025 Mar 23;24(1):94. doi: 10.1186/s12936-025-05282-0.
3
msp1, msp2, and glurp genotyping to differentiate Plasmodium falciparum recrudescence from reinfections during prevention of reestablishment phase, Sri Lanka, 2014-2019.

本文引用的文献

1
-associated changes in human odor attract mosquitoes.与人类气味相关的变化会吸引蚊子。
Proc Natl Acad Sci U S A. 2018 May 1;115(18):E4209-E4218. doi: 10.1073/pnas.1721610115. Epub 2018 Apr 16.
2
Plasmodium falciparum parasites with histidine-rich protein 2 (pfhrp2) and pfhrp3 gene deletions in two endemic regions of Kenya.肯尼亚两个流行地区存在缺失组氨酸丰富蛋白 2(pfhrp2)和 pfhrp3 基因的恶性疟原虫寄生虫。
Sci Rep. 2017 Nov 7;7(1):14718. doi: 10.1038/s41598-017-15031-2.
3
Spread of artemisinin resistance in Plasmodium falciparum malaria.
2014 - 2019年斯里兰卡预防再感染阶段,采用msp1、msp2和glurp基因分型鉴别恶性疟原虫复发与再感染情况
Malar J. 2024 Jan 27;23(1):35. doi: 10.1186/s12936-024-04858-6.
4
Rapid monitoring of SARS-CoV-2 variants of concern through high-resolution melt analysis.通过高分辨率熔解分析快速监测 SARS-CoV-2 关注变体。
Sci Rep. 2023 Dec 7;13(1):21598. doi: 10.1038/s41598-023-48929-1.
5
Genetic diversity of among asymptomatic pregnant women on intermittent preventive treatment with sulfadoxine-pyrimethamine in Nigeria.尼日利亚无症状孕妇中磺胺多辛-乙胺嘧啶间歇性预防治疗的遗传多样性。
Afr Health Sci. 2023 Mar;23(1):765-773. doi: 10.4314/ahs.v23i1.80.
6
A high-resolution melt curve toolkit to identify lineage-defining SARS-CoV-2 mutations.一种用于鉴定 SARS-CoV-2 谱系定义突变的高分辨率熔解曲线工具包。
Sci Rep. 2023 Mar 8;13(1):3887. doi: 10.1038/s41598-023-30754-1.
7
Baseline prevalence of molecular marker of sulfadoxine/pyrimethamine resistance in Ebonyi and Osun states, Nigeria: amplicon deep sequencing of dhps-540.尼日利亚埃邦伊州和奥孙州磺胺多辛/乙胺嘧啶耐药分子标志物的基线流行率:dhps-540 的扩增子深度测序。
J Antimicrob Chemother. 2023 Mar 2;78(3):788-791. doi: 10.1093/jac/dkad011.
8
Monitoring of the Sensitivity In Vivo of to Artemether-Lumefantrine in Mali.马里青蒿琥酯-甲氟喹体内敏感性监测。 (原英文题目表述似乎有误,推测应该是“Monitoring of the Sensitivity In Vivo of Artemisia annua to Artemether-Lumefantrine in Mali”之类,这里按照纠正后的内容翻译,若不是这种情况请根据正确原文调整)
Trop Med Infect Dis. 2021 Jan 24;6(1):13. doi: 10.3390/tropicalmed6010013.
9
A novel multiplex qPCR assay for detection of Plasmodium falciparum with histidine-rich protein 2 and 3 (pfhrp2 and pfhrp3) deletions in polyclonal infections.一种用于检测恶性疟原虫的新型多重 qPCR 检测方法,该方法可检测到含有组氨酸丰富蛋白 2 和 3(pfhrp2 和 pfhrp3)缺失的多克隆感染。
EBioMedicine. 2020 May;55:102757. doi: 10.1016/j.ebiom.2020.102757. Epub 2020 May 8.
10
Amplicon deep sequencing improves Plasmodium falciparum genotyping in clinical trials of antimalarial drugs.扩增子深度测序提高了抗疟药物临床试验中恶性疟原虫的基因分型。
Sci Rep. 2019 Nov 28;9(1):17790. doi: 10.1038/s41598-019-54203-0.
疟原虫青蒿素耐药性的传播。
N Engl J Med. 2014 Jul 31;371(5):411-23. doi: 10.1056/NEJMoa1314981.
4
Directional selection at the pfmdr1, pfcrt, pfubp1, and pfap2mu loci of Plasmodium falciparum in Kenyan children treated with ACT.在接受青蒿素联合疗法治疗的肯尼亚儿童中,恶性疟原虫的pfmdr1、pfcrt、pfubp1和pfap2mu基因座的定向选择。
J Infect Dis. 2014 Dec 15;210(12):2001-8. doi: 10.1093/infdis/jiu358. Epub 2014 Jul 3.
5
Evaluation of parasite subpopulations and genetic diversity of the msp1, msp2 and glurp genes during and following artesunate monotherapy treatment of Plasmodium falciparum malaria in Western Cambodia.评价柬埔寨西部恶性疟原虫青蒿琥酯单药治疗期间和之后虫株亚群及 msp1、msp2 和 glurp 基因遗传多样性。
Malar J. 2013 Nov 9;12:403. doi: 10.1186/1475-2875-12-403.
6
Culture-adapted Plasmodium falciparum isolates from UK travellers: in vitro drug sensitivity, clonality and drug resistance markers.从英国旅行者中分离出的具有文化适应性的恶性疟原虫:体外药物敏感性、克隆性和耐药性标志物。
Malar J. 2013 Sep 13;12:320. doi: 10.1186/1475-2875-12-320.
7
Residual Plasmodium falciparum parasitemia in Kenyan children after artemisinin-combination therapy is associated with increased transmission to mosquitoes and parasite recurrence.在肯尼亚儿童中,青蒿素联合疗法治疗后残留的疟原虫寄生虫血症与增加向蚊子传播和寄生虫复发有关。
J Infect Dis. 2013 Dec 15;208(12):2017-24. doi: 10.1093/infdis/jit431. Epub 2013 Aug 14.
8
Malaria transmission after artemether-lumefantrine and dihydroartemisinin-piperaquine: a randomized trial.青蒿琥酯-咯萘啶和双氢青蒿素-哌喹治疗后疟疾传播:一项随机试验。
J Infect Dis. 2013 Jun 1;207(11):1637-45. doi: 10.1093/infdis/jit077. Epub 2013 Mar 6.
9
Rapid, field-deployable method for genotyping and discovery of single-nucleotide polymorphisms associated with drug resistance in Plasmodium falciparum.快速、现场可部署的方法,用于基因分型和发现与恶性疟原虫耐药性相关的单核苷酸多态性。
Antimicrob Agents Chemother. 2012 Jun;56(6):2976-86. doi: 10.1128/AAC.05737-11. Epub 2012 Mar 19.
10
How much remains undetected? Probability of molecular detection of human Plasmodia in the field.有多少未被发现?现场人类疟原虫分子检测的概率。
PLoS One. 2011 Apr 28;6(4):e19010. doi: 10.1371/journal.pone.0019010.